产品名称 | NebuSelect™ Recombinant Biotinylated Human Siglec-5/CD170 , hFc-tag |
---|---|
目录号 | NBL-242114 |
别名 | Siglec-5/CD170; CD170; CD33 antigen-like 2; CD33L2; OBBP2; Siglec5; SIGLEC5; OB-BP2 |
外观 | see COA |
分子量 | Glu17-Thr434 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | O15389 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242114-100ug | 100ug | Inquire | Inquire | |
NBL-242114-1mg | 1mg | Inquire | Inquire | |
NBL-242114-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human Siglec-5/CD170 , hFc-tag
Catalog#:
NBL-242114
Description:
NebuSelect™ Recombinant Biotinylated Human Siglec-5/CD170 , hFc-tag(Cat#NBL-242114) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Glu17-Thr434.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 73.1 kDa. Due to glycosylation, the protein migrates to 90-115 kDa based on Bis-Tris PAGE result.
Target Name:
Siglec-5/CD170; CD170; CD33 antigen-like 2; CD33L2; OBBP2; Siglec5; SIGLEC5; OB-BP2
Target Information:
Group B Streptococcus (GBS) causes invasive infections in human newborns. the GBS β-protein attenuates innate immune responses by binding to sialic acid-binding immunoglobulin-like lectin 5 (Siglec-5), an inhibitory receptor on phagocytes.the polymorphism could influence the risk of prematurity among human fetuses of mothers colonized with GBS. This first functionally proven example of a paired receptor system in the Siglec family has multiple implications for regulation of host immunity.
Amino Acid Sequence:
Glu17-Thr434
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.